Skip to main content
HongShan China logo

HongShan China

Venture CapitalHong Kong, Hong KongSee on the maphongshan.com

technologyhealthcareconsumer

HongShan China is a private equity investment firm focused on technology, healthcare, and consumer sectors. It invests from seed and early stages through growth, mergers and acquisitions, and public markets.

2
Portfolio companies on reccy
0
Hiring now
0
Open roles in the portfolio
Jul 2026
Latest portfolio round

Hiring now in the portfolio0

None of their companies on reccy has an open role right now. Browse all neurotech roles

Portfolio on reccy2

Their companies, round by round

  • GestalaChengdu, China

    Brain-computer interfaces · Neuromodulation

    • Jul 2026Angel · $61.9MLed
    • Mar 2026Angel · $21.8M
  • Brain-computer interfaces

    • Sep 2026Series B · $89.6M
    • Feb 2026Series A · $43.4M
    • Aug 2025Series A · $41.8M
    • Jul 2024Seed
    • Aug 2023Angel
    • Jan 2023Seed

Rounds marked Led list HongShan China as a lead investor; the rest are the company's other funding.

Recent rounds in the portfolio

  • Jul 2026

    Gestala · Angel $61.9MLead

    With C Capital, CEC Data Capital, China Electronics Health Fund, CTS Capital, Dalton Venture, Furong Capital, Gobi Partners, GoldTech Venture Capital, Guosheng Capital, Huaying Capital, Lens Technology, Lingang Sci-Tech Investment, Lingang Technology Investment, Meridian Capital, Seas Capital, Sinovation Ventures

Portfolio in the news